盘点:细数“避孕药”的功与过!

2016-09-08 MedSci MedSci原创

口服避孕药,通常被称为避孕药,是一种激素避孕药,美国每年大约有1200万名妇女采用口服避孕药的方式避孕。避孕药是一种非常有效的避孕方法。每年约8%的女性因忘记服用避孕药而发生意外怀孕。然而,若每天同一时刻服用避孕药,100位女性中只有一位会在使用避孕药的第一年内意外怀孕。除了能避孕,还存在以下几大好处: 1,10年调查发现,口服避孕药可降低癌症死亡率近日,发表在《Annals of

口服避孕药,通常被称为避孕药,是一种激素避孕药,美国每年大约有1200万名妇女采用口服避孕药的方式避孕。避孕药是一种非常有效的避孕方法。每年约8%的女性因忘记服用避孕药而发生意外怀孕。然而,若每天同一时刻服用避孕药,100位女性中只有一位会在使用避孕药的第一年内意外怀孕。

除了能避孕,还存在以下几大好处: 

1,10年调查发现,口服避孕药可降低癌症死亡率

近日,发表在《Annals of Oncology》杂志上的一项国际性调查表明,在2002年至2012年间,美国及欧盟的卵巢癌死亡人数持续下降,另外,日本的卵巢癌死亡率也有小幅度下降。

该研究由意大利米兰大学医学院Carlo La Vecchia 医学教授引领,研究人员表示,口服避孕药以及长期采用卵巢癌预防措施是卵巢癌死亡率下降的主要原因,利用激素替代疗法(HRT)来应对更年期可能也起到一定的作用。

研究人员还预测了至2020年英国、德国、意大利、波兰、西班牙、英国、整个美国以及日本的卵巢癌年龄标准化死亡率的变化。他们预计,美国将有15%的下降率,欧盟和日本的下降率将为10%,欧洲的六个国家中,只有西班牙表现出每10万女性的平均死亡率人数从3.7上升至3.9。 La Vecchia教授解释,“这可能是由于这些中年或老年女性在年轻时都不太可能服用避孕药。”(文章详见--10年调查发现,口服避孕药可降低癌症死亡率

2,减重和避孕药可改善PCOS患者的生活质量

近期研究表明,使用激素避孕药和密集的生活方式干预,无论是单独或两者组合,均能改善超重或肥胖多囊卵巢综合征(PCOS)患者与生活质量相关的身体和心理、抑郁和焦虑症状。

宾夕法尼亚大学医院妇科的Anuja Dokras博士对132名21-40岁的PCOS女性患者进行了研究。参与者被随机分配到一个连续口服避孕药组(n = 45)、密集的生活方式干预组(n = 44)或两者组合(n = 43),进行长达16周的试验。干预包括热量限制、增加运动和改变生活方式的咨询等。

口服避孕药和减肥战略管理等多囊卵巢综合征的常用治疗方法,对患者的症状、焦虑症状和整体健康相关的生活质量有益。(文章详见--减重和避孕药可改善PCOS患者的生活质量

3,自发性卵巢早衰的女性,联合激素替代疗法较口服避孕药可更好的提高腰椎的骨密度

卵巢早衰(POF)的女性通常存在长时间的雌激素缺乏,导致的其中一个主要后果是骨丧失。目前最佳的雌激素替代疗法尚未可知,且其管理也并未有研究支持。联合激素替代疗法(HRT)或联合口服避孕药(COCP)是其中的两大重要的治疗方法。

研究共纳入59名自发性POF的女性,年龄为18-44岁。30名女性接受治疗并进行随机接受HRT和COCP治疗,29名女性接受下降治疗。

结果表明,对于自发性POF的女性来说,在增加腰椎骨密度上HRT优于COCP。但是该研究的样本量较小失访率较高,仍需进一步的研究以证实此研究发现。但是,尚未发现哪种治疗方法明显优于其他治疗方法。(文章详见--J Clin Endocrinol Metab:自发性卵巢早衰的女性,联合激素替代疗法较口服避孕药可更好的提高腰椎的骨密度

4,避孕药能预防运动性膝盖损伤

德克萨斯大学医学分校的研究人员发现,口服能降低并稳定雌激素水平的避孕药的女性膝盖严重受伤的概率比其他女性小。这一研究成果已经发表在《体育运动药物科学》上,这个期刊是美国运动医学协会的官方杂志。

本研究的第一作者博士生Aaron Gray表示,避孕药能使女性的雌激素水平保持较低且更稳定,这就可能避免周期性的ACL减弱。考虑到这一点,williamhill asia 研究了口服避孕药能否避免需要矫型手术的严重ACL损伤的发生。需要ACL重建手术女性最多的年龄段是15-19岁,这些女性如果服用避孕药就会降低22%膝盖ACL损伤的风险。

Gray认为青春期的激素变化可能导致这个年龄段女性ACL损伤较多的原因。青春期女性的雌激素会突然大幅上升,同时腿部也会生长骤增。生长骤增后,这些青少年需要一段时间才能开始协调地运用突然长长的四肢。目前,年轻运动员因为各种原因服用避孕药,如为了月经周期更规律,周期间隔更长等。如果有进一步前瞻性研究,为了降低受伤率也可能成为女运动员服用避孕药的原因之一。(文章详见--避孕药能预防运动性膝盖损伤

避孕药虽好,但也不要多吃,以免增加患癌风险!

1,增加脑瘤风险

年轻妇女服用激素避孕药与胶质瘤之间存在关联,并增加了患病风险。研究发表在Br J Clin Pharmacol杂志上。

研究者使用丹麦卫生和行政登记的数据,选取了2000年至2009年间年龄在15岁至49岁之间初次诊断为脑胶质瘤的女性。登记机构提供了1995年至2009年接受激素避孕处方的女性信息。服任意一种避孕药都可导致胶质瘤患病风险增加。服用避孕药不足一年者,比值比为1.4(95% CI, 0.8- 2.3);服用5年或以上避孕药者,他们的比值比是1.9 (95% CI, 1.2- 2.9)。(文章详见--Br J Clin Pharmacol:服用避孕药增加脑瘤风险

2,或增加乳腺癌发病风险

使用口服避孕药的女性发生乳腺癌的风险,比以前曾使用或从不使用口服避孕药的女性增加50%,该研究发表在Cancer Res杂志上。

研究者比较了1990~2009年期间1102例年龄20~49岁、曾被诊断为浸润性乳腺癌的女性患者和21755名来自相同医疗系统且年龄、年份、入组时间长度和医疗情况匹配的对照者。上述结果提示,风险大小可能因口服避孕药剂型而异。研究者发现,乳腺癌与近期使用口服避孕药的之间的显著相关性涉及大剂量雌激素(OR,2.7;95% CI,1.1~6.2)、ethynodiol diacetate(OR,2.6;95% CI,1.4~4.7)和triphasic剂量norethindrone平均0.75 mg(OR,3.1;95% CI,1.9~5.1)。但是其他类型的口服生育控制药物,包括小剂量雌激素口服避孕药,与乳腺癌无关(OR,1.0;95% CI,0.6~1.7)。(文章详见--Cancer Res:近期使用口服避孕药或增乳腺癌发病风险

3.增加HIV生殖道感染

俄亥俄州立大学医学中心的研究者发现,因为艾滋病毒和其它性传播病毒必须穿透生殖器粘膜屏障才能感染,所以研究人员试图找出削弱生殖器粘膜屏障防御的因素。

他们的研究最近发表在Mucosal Immunology杂志上,文章显示用甲孕酮(DMPA)或左炔诺孕酮(LNG)治疗后显著增加了雌性小鼠生殖道病毒感染易感性。(文章详见--Mucosal Immunol:激素类避孕药会增加HIV生殖道感染

4.可诱发女性癫痫发作

近期发表在Epilepsy Research的研究称,口服避孕药的主要成分乙炔雌二醇会增加癫痫患者发作频率,损害癫痫患者的大脑。德州农工健康科学中心大学医学院的D. Samba Reddy博士,也是研究的主要作者,他说“先前对癫痫女性的研究表明,激素类避孕药会导致患者癫痫发作更频繁,差不多是不服用这些口服避孕药患者的4.5倍!”

这项癫痫动物模型的研究显示,乙炔雌二醇不仅会导致癫痫发作频率更高,还会让癫痫越来越不容易控制!(文章详见--Epilepsy Res:激素类避孕药可诱发女性癫痫发作

5,口服避孕药脑静脉血栓形成风险大

近期发表在JAMA Neurology的研究称,口服避孕药的肥胖女性,与没有口服避孕药的正常体重女性相比,脑静脉血栓形成(CVT)的风险更大。

研究者指出,口服避孕药的肥胖女性,与没有口服避孕药的正常体重女性相比,CVT风险增加近30倍!口服避孕药的超重女性CVT风险同样增加。不过没有使用口服避孕药肥胖人群无论男女,对CVT风险不会产生影响。

作者总结说:“口服避孕药的肥胖女性VTE和CVT的风险如此之高,可能会导致临床医生不愿开具口服避孕药处方给肥胖人群。不过,虽然潜在的相对风险增加了,但是CVT的绝对风险仍很低。不过,口服避孕药会增加意外怀孕风险,进而增加妊娠相关血栓事件的风险。临床上应告知口服避孕药的肥胖人群,其血栓形成风险会增高,尤其是还存在其他危险因素的情况下。这类女性可以选择与血栓形成无关的其他避孕方式如宫内节育器,以避免风险的增加。”(文章详见--口服避孕药脑静脉血栓形成风险大

本文系williamhill asia 医学(MedSci)原创编译整理,欢迎转载!

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=114702, encodeId=10db114e029a, content=了解以前没有认识的领域知识,赞一个。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49751646903, createdName=曦西嘻, createdTime=Thu Sep 08 23:34:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114618, encodeId=47601146183f, content=很好的文章,学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Thu Sep 08 22:28:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114290, encodeId=06a51142901d, content=阅读了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Sep 08 17:44:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114092, encodeId=89c8114092a5, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114093, encodeId=ce0c11409313, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114072, encodeId=1e231140e21c, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114073, encodeId=02121140e302, content=谢谢分享,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114074, encodeId=7e4c1140e4f6, content=很不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-08 曦西嘻

    了解以前没有认识的领域知识,赞一个。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=114702, encodeId=10db114e029a, content=了解以前没有认识的领域知识,赞一个。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49751646903, createdName=曦西嘻, createdTime=Thu Sep 08 23:34:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114618, encodeId=47601146183f, content=很好的文章,学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Thu Sep 08 22:28:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114290, encodeId=06a51142901d, content=阅读了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Sep 08 17:44:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114092, encodeId=89c8114092a5, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114093, encodeId=ce0c11409313, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114072, encodeId=1e231140e21c, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114073, encodeId=02121140e302, content=谢谢分享,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114074, encodeId=7e4c1140e4f6, content=很不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-08 KO229256262

    很好的文章,学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=114702, encodeId=10db114e029a, content=了解以前没有认识的领域知识,赞一个。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49751646903, createdName=曦西嘻, createdTime=Thu Sep 08 23:34:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114618, encodeId=47601146183f, content=很好的文章,学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Thu Sep 08 22:28:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114290, encodeId=06a51142901d, content=阅读了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Sep 08 17:44:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114092, encodeId=89c8114092a5, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114093, encodeId=ce0c11409313, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114072, encodeId=1e231140e21c, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114073, encodeId=02121140e302, content=谢谢分享,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114074, encodeId=7e4c1140e4f6, content=很不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-08 刘煜

    阅读了谢谢。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=114702, encodeId=10db114e029a, content=了解以前没有认识的领域知识,赞一个。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49751646903, createdName=曦西嘻, createdTime=Thu Sep 08 23:34:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114618, encodeId=47601146183f, content=很好的文章,学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Thu Sep 08 22:28:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114290, encodeId=06a51142901d, content=阅读了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Sep 08 17:44:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114092, encodeId=89c8114092a5, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114093, encodeId=ce0c11409313, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114072, encodeId=1e231140e21c, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114073, encodeId=02121140e302, content=谢谢分享,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114074, encodeId=7e4c1140e4f6, content=很不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-08 知难而进

    谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=114702, encodeId=10db114e029a, content=了解以前没有认识的领域知识,赞一个。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49751646903, createdName=曦西嘻, createdTime=Thu Sep 08 23:34:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114618, encodeId=47601146183f, content=很好的文章,学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Thu Sep 08 22:28:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114290, encodeId=06a51142901d, content=阅读了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Sep 08 17:44:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114092, encodeId=89c8114092a5, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114093, encodeId=ce0c11409313, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114072, encodeId=1e231140e21c, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114073, encodeId=02121140e302, content=谢谢分享,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114074, encodeId=7e4c1140e4f6, content=很不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-08 知难而进

    继续关注!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=114702, encodeId=10db114e029a, content=了解以前没有认识的领域知识,赞一个。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49751646903, createdName=曦西嘻, createdTime=Thu Sep 08 23:34:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114618, encodeId=47601146183f, content=很好的文章,学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Thu Sep 08 22:28:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114290, encodeId=06a51142901d, content=阅读了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Sep 08 17:44:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114092, encodeId=89c8114092a5, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114093, encodeId=ce0c11409313, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114072, encodeId=1e231140e21c, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114073, encodeId=02121140e302, content=谢谢分享,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114074, encodeId=7e4c1140e4f6, content=很不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-08 医路开来

    学习啦,,,

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=114702, encodeId=10db114e029a, content=了解以前没有认识的领域知识,赞一个。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49751646903, createdName=曦西嘻, createdTime=Thu Sep 08 23:34:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114618, encodeId=47601146183f, content=很好的文章,学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Thu Sep 08 22:28:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114290, encodeId=06a51142901d, content=阅读了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Sep 08 17:44:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114092, encodeId=89c8114092a5, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114093, encodeId=ce0c11409313, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114072, encodeId=1e231140e21c, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114073, encodeId=02121140e302, content=谢谢分享,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114074, encodeId=7e4c1140e4f6, content=很不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-08 医路开来

    谢谢分享,,

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=114702, encodeId=10db114e029a, content=了解以前没有认识的领域知识,赞一个。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49751646903, createdName=曦西嘻, createdTime=Thu Sep 08 23:34:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114618, encodeId=47601146183f, content=很好的文章,学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/17/3872cad7a53dc9dcbd08202fb6313cf4.jpg, createdBy=2cb71609450, createdName=KO229256262, createdTime=Thu Sep 08 22:28:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114290, encodeId=06a51142901d, content=阅读了谢谢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Thu Sep 08 17:44:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114092, encodeId=89c8114092a5, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114093, encodeId=ce0c11409313, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 14:49:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114072, encodeId=1e231140e21c, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114073, encodeId=02121140e302, content=谢谢分享,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114074, encodeId=7e4c1140e4f6, content=很不错的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 08 14:36:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-08 医路开来

    很不错的文章

    0

相关威廉亚洲官网

伟大的20微克|williamhill asia 欠她一个“平反”

短效避孕药和紧急避孕药并不是一回事。他们简直就像西瓜和冬瓜的差别一样大……紧急避孕药是用于发生无保护性行为之后的补救措施。短效避孕药需要女性每天服用一粒,最好是同一时间段。

JCEM:使用含雌激素避孕药可增加25(OH)D的浓度

既往小型研究已经表明外源性雌激素可能改善维生素D的水平,但是其机制并不清楚,因为使用激素的女性其选择的生活方式可能会影响维生素D的状态。本研究旨在探究激素避孕与25羟基维生素D(25(OH)D)之间的关联。 采用横截面数据的线性回归模型来评估校正其他混杂因素后,季节调整后的血清25(OH)D与雌激素使用之间的关联。 研究共纳入了1662名参与子宫肌瘤队列研究的非裔美国妇女,年龄在23

J Clin Endocrinol Metab:含雌激素的避孕药可增加血清25(OH)D浓度

背景和目的:小的研究表明外源性雌激素可能改善维生素D的状态,但因果关系目前还不清楚,因为使用激素的妇女可能会改变生活方式的选择,差异影响维生素D的状态。研究者进行了一项研究,调查使用激素避孕和25羟基维生素D(25(OH)D)之间的关联。方法:使用横截面数据的线性回归模型估计季节调整后的血清25(OH)D和雌激素使用之间的关系;研究共纳入了1662名非裔美国女性,年龄23-34岁,获取了血液样本、

J Clin Endocrinol Metab:减重和避孕药可改善PCOS患者的生活质量

近期研究表明,使用激素避孕药和密集的生活方式干预,无论是单独或两者组合,均能改善超重或肥胖多囊卵巢综合征(PCOS)患者与生活质量相关的身体和心理、抑郁和焦虑症状。宾夕法尼亚大学医院妇科的Anuja Dokras博士对132名21-40岁的PCOS女性患者进行了研究。参与者被随机分配到一个连续口服避孕药组(n = 45)、密集的生活方式干预组(n = 44)或两者组合(n = 43),进行长达16

盘点:避孕,能用‘套’就少用‘药’

口服避孕药,通常被称为避孕药,是一种激素避孕药,美国每年大约有1200万名妇女采用口服避孕药的方式避孕。避孕药是一种非常有效的避孕方法。每年约8%的女性因忘记服用避孕药而发生意外怀孕。然而,若每天同一时刻服用避孕药,100位女性中只有一位会在使用避孕药的第一年内意外怀孕。小编贴心整理这篇奉献给这个七夕夜,毕竟一年只见一面,好好珍惜吧! 【1】增加静脉血栓栓塞的发生

BMJ:避孕药所致的急性肝炎——病例报道

女性患者,19岁,因右上腹部疼痛和腹胀加重而就诊。检查可见患者存在黄疸和腹水。肝尾状叶水平肝脏增强门静脉期CT显示如下图所示。 CT显示肝肿大,肝脏和肝尾状叶的异质性增强(C)。这些结果符合继发于肝静脉闭塞的Budd-Chiari综合征。 Budd-Chiari综合征的发病率约为1/100万,其特点是肝静脉血液流出道阻塞,导致瘀血和肝肿大。血液经尾状叶至下腔静脉。尾状叶